Esomeprazole claimed to have higher oral bioavailability and to produce better control of intragastric pH in GERD (Gastroesophageal reflux disease) patients because of slower elimination and longer t½. Higher healing rates of erosive esophagitis and better GERD symptom relief.
As per the best practices of the company, we assure you that the information provided herein is factual,
truthful, up-to-date, and complete. It is very important to note that this report should not be used in lieu
of physical medical consultation/advice. We do not guarantee the authenticity or credibility of the
data/information presented. The absence of any details and/or warning/notice to any drugs & medicine
shall not be deemed or assumed to be an implied assurance of the Company. We accept no
responsibility for the consequences due to the aforementioned data/information and in case of any
doubts or queries, we strongly advise you to seek a physical consultation.